Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 03, 2018 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 29,803 | -- | 503,010 | |
| Oct 01, 2020 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 29,900 | $14.02 | 840,913 | |
| Sep 01, 2020 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 29,900 | $14.18 | 850,813 | |
| May 19, 2017 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 29,914 | $8.00 | 474,438 | |
| May 15, 2017 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 29,914 | $8.00 | 504,352 | |
| Jan 02, 2024 | Chief Legal Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | $5.16 | 372,285 | |
| Jan 02, 2024 | Chief Legal Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $14.21 | 342,285 | |
| Jan 02, 2024 | Chief Legal Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 30,000 | |
| Dec 26, 2023 | Chief Legal Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | $5.16 | 372,285 | |
| Dec 26, 2023 | Chief Legal Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $14.00 | 342,285 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.